MYH14 and cardiomyopathy: Implications for sarcomere-targeted treatment of cardiomyopathies. Myosin inhibitors have been proposed as a therapeutic strategy to curb the excessive contractility and impaired relaxation seen in Hypertrophic Cardiomyopathy (HCM).